PHARMINNOVA P.C. is an experienced, consulting group focused on the global pharmaceutical industry, covering services for an extensive portfolio of medicinal products.
We are always up to date with current legislation, regulatory requirements, industry initiatives and interpretations of the regulations and scientific guidelines. PHARMINNOVA scientific staff and collaborating experts will ensure that you have access to the right level of skills and experience, along with the flexibility that your project requires. Having previous work experience inside regulatory agencies at the national and international level, as well as within pharma industry, bring a unique level of insight and expertise to our work. Our ability to respond quickly and flexibly to ever-changing client needs in a complex regulatory environment combined with a consistent and dedicated commitment to quality services are important elements of advantage.
PHARMINNOVA experts, having vast experience in a variety of areas, such as strategic and scientific advice, regulatory affairs, business and product development, dossier compilation etc, develop creative approaches to assist you in bringing your products to any market.
The aim of PHARMINNOVA is to provide our customers with a reliable, flexible and effective strategic regulatory and scientific affairs service, covering all stages of pharmaceutical development and authorisation process in a timely and cost-effective manner. Our mission is to assist pharmaceutical companies in rationalizing drug development and we use innovative approaches and services, in order to translate the scientific knowledge into tangible benefits for patient care.
Guiding you all the way up
Founder/Managing Director and Senior Consultant
Chrysa Daousani is the Founder/Managing Director and Senior Consultant of PHARMINNOVA P.C.
Chrysa is an Expert in Clinical/Pharmacokinetic and Non-clinical assessment and regulatory science,
being a Consultant in the Pharma Industry, since early 2014.
Before that, she worked as a Clinical/Pharmacokinetic and Non-Clinical Assessor at the Greek National
Organisation for Medicines-EOF (2003-2014), where she coordinated and provided assessment for
Centralised, Decentralised, Mutual Recognition and National procedures for medicinal products for
human use, as well as for scientific and regulatory advice.
During her engagement in the Greek Agency, she represented Greece as EOF delegate in the Committee
for Medicinal Products for Human Use-CHMP at the European Medicines Agency (EMA) (2012-2014) and also in the Co-ordination Group for Mutual
Recognition and Decentralised procedure-CMDh (2008-2014).
She holds a B.Sc. in Pharmacy from Department of Pharmacy, University of Athens, Greece, where she
has also gained her M.Sc. and Ph.D. (Section of Pharmaceutical Chemistry, Laboratory of Pharmaceutical
Analysis).
Her scientific interests include areas such as biopharmaceutics, pharmacokinetics and bioequivalence,
bioanalysis/bioanalytical methods, drug ADME-T processes, modeling and simulation (M&S) in drug
development.
PHARMINNOVA is in close collaboration with experienced and reliable partners worldwide (including CROs, CDMOs, Pharma Companies, as well as with Academic Institutions), utilized on a per-project basis.
Our clients include many pharmaceutical companies around the world.